0 results available. Select is focused ,type to refine list, press Down to open the menu,
AXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye ey...
The following section summarizes insights on Axim Biotechnologies Inc's EV / Free Cash Flow:
We've identified the following companies as similar to Axim Biotechnologies Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / Free Cash Flow in the valuation category include:
Measures the dollars in Enterprise Value for each dollar of free cash flow over the last twelve months.
Enterprise Value / Free Cash Flow measures the dollars in Enterprise Value for each dollar of unlevered free cash flow earned over the last 12 months.
TEV / UFCF = Total Enterprise Value / Unlevered Free Cash Flow
Applying this formula, AXIM Biotechnologies’s EV/FCF is calculated below:
Total Enterprise Value [ $7.825 M ]
(/) Unlevered Free Cash Flow [ -$3.374 M ]
(=) TEV / UFCF [ −2.3x ]
The tables below summarizes the trend in AXIM Biotechnologies’s EV/FCF over the last five years:
| Date | Enterprise Value | Unlevered Free Cash Flow | TEV / UFCF |
|---|---|---|---|
| 2019-12-31 | $8.124 M | -$794.014 T | −10.2 |
| 2020-12-31 | $155.6 M | -$5.96 M | −26.1 |
| 2021-12-31 | $53.085 M | -$4.904 M | −10.8 |
| 2022-12-31 | $9.121 M | -$1.021 M | −8.9 |
| 2023-12-31 | -$6.28 M | $655.658 T | −9.6 |
Read more about total enterprise value (tev) and unlevered free cash flow
The chart above depicts the distribution of ev / free cash flow for companies operating in the Healthcare sector in the Developed economic region. Over 2,190 companies were considered in this analysis, and 2,105 had meaningful values. The average ev / free cash flow of companies in the sector is -0.8x with a standard deviation of 26.4x.
Axim Biotechnologies Inc's EV / Free Cash Flow of -2.3x ranks in the 45.9% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,193 |
| Included Constituents | 2,105 |
| Min | -125.4x |
| Max | 107.5x |
| Median | -1.7x |
| Mean | -0.8x |
| Standard Deviation | 26.4x |
You can find companies with similar ev / free cash flow using this stock screener.